MHMuhammad Mansoor Ul Haq

Muhammad Mansoor Ul Haq

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammad Mansoor Ul Haq has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The efficacy of levofloxacin‐based sequential regimen to eradicate Helicobacter pylori infection

    by Muhammad Mansoor Ul Haq, Muhammad Furqan, Ayesha Zia, Ayesha Khalil, Hamid Ali Kalwar

  • Open Access

    Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective

    by Muhammad Mansoor-Ul-Haq, Abdul Latif, Mansoor Asad, Farooque Aziz Memon

    Gastric varices (GV) are less commonly seen but bleed more severely than esophageal varices (EV). Transjugular intrahepatic portosystemic shunt (TIPS), alcohol injection, and N-butyl-2-cyanoacrylate (NBCA) are generally used for GV bleed management. NBCA is usually injected endoscopically and is known to be quite successful in the treatment of GV bleeding. This study was conducted with the objective of determining the outcomes in patients with GV treated with NBCA. We conducted a retrospective review of medical records and reports of endoscopy performed between March 2015 and June 2018 at a large tertiary care center. Patients of any age and gender having a history of chronic liver disease, those presenting with hematemesis or melena, and those who were found to have GV bleed on endoscopy and treated with NBCA were included. All the endoscopy procedures were undertaken within 24 hours of admission. Informed written consent was obtained from all the patients before the procedure. The outcomes were measured in terms of rate of mortality, hemostasis achieved, duration of stay at the hospital, and requirement of blood transfusion. A total of 31 patients met the inclusion criteria; (58.1%) were males and 13 (41.9%) were females. The mean age was 55.23 ±8.77 years; 12.9% were Child-Pugh class-A, 64.5% were class B, and 22.6% were class C. Out of the 31 patients, 27 (87%) patients achieved hemostasis. Moreover, 22 (71%) patients had hospital stay ranging between 5-8 days. The overall mortality rate was 9.7% (3 patients). No complication was reported from NBCA injection. The injection of NBCA can provide a safe and effective method for the management of GV bleeding as demonstrated by the results of our study, which showed hemostasis in a majority of the cases after the initial injection with no procedure-related complications, a reduced hospital stay, and a reduced rate of mortality.


  • Midazolam for sedation during diagnostic or therapeutic upper gastrointestinal endoscopy in cirrhotic patients

    by Muhammad M. Haq, Nabiha Faisal, Ayesha Khalil, Syed A. H. Haqqi, Hafeezullah Shaikh, Nazim Arain

    Aim The objective of this study was to determine the frequency of clinically overt hepatic encephalopathy (HE) in cirrhotic patients undergoing diagnostic or therapeutic upper gastrointestinal endoscopy (UGE) who received midazolam for sedation. Methods This was an interventional study carried out at Liaquat National Hospital, Karachi. Consecutive patients presenting to the service of a single consultant gastroenterologist for diagnostic or therapeutic UGE between January 2009 and January 2011, who fulfilled the inclusion and exclusion criteria, were prospectively recruited for the study. The administration of intravenous midazolam was carried out in an incremental manner, whereas pulse and oxygen saturation was monitored during every procedure. During the recovery period, the degree of alertness was measured at 2, 4, and 6 h by the resident using the observer’s assessment of alertness and sedation score and time to full recovery was determined. Results A total of 191 consecutive patients who underwent diagnostic or therapeutic UGE fulfilling the inclusion and exclusion criteria were recruited. The mean age was 51.30±10.7 years, with an age range of 12–75 years. The majority of the patients were men (n=108, 56.5%), with 83 women (43.5%). A total of eight patients (4.2%) remained drowsy and developed clinically overt HE after the procedure on assessment at 2 and 4 h. However, all of these patients regained full consciousness at 6 h spontaneously. Among those eight patients who developed clinically overt HE, seven (87.5%) were Child–Pugh class C and one patient (12.5%) was Child–Pugh class B. Overt HE was significantly related to Child–Pugh class (P=0.005) and the dose of midazolam (P=0.02). Conclusion We concluded that intravenous midazolam can be used safely in cirrhotic patients of Child–Pugh class A and B undergoing UGE for conscious sedation, but caution should be exercised for patients with advanced liver disease.